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Wavelet transform of polarized fluorescence spectra of human breast tissues is found 
to localize spectral features that can reliably differentiate normal and malignant tissue 
types. The intensity differences of parallel and perpendicularly polarized fluorescence 
spectra are subjected to investigation, since the same is relatively free of the diffusive 
background. A number of parameters, capturing spectral variations and subtle changes 
in the diseased tissues in the visible wavelength regime, are clearly identifiable in the 
wavelet domain. These manifest both in the average low pass and high frequency high 
pass wavelet coefficients.
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    Introduction
    Breast cancer has emerged as the most common disease amongst women. Although the risk factor 
for Asian women has been estimated to be one-fifth to one-tenth that of women in North America and 
Western Europe, it still is the second most malignant condition.1,2 Apart from genetic predisposition, a 
number of factors like diet, exercise, environment, etc., are being recognized to play major roles in the 
growth of the disease.3 Early diagnosis is still not possible through conventional diagnostic techniques. 
If diagnosed early, breast cancer is also one of the most treatable forms of cancer. The requirement of 
continuous monitoring for breast malignancy of a significant percentage of women population has led 
to an intense search for safe, reliable and fast diagnostic methods.
    Optical diagnosis methods are now emerging as viable tools for tumor detection. Of these, 
fluorescence techniques are being increasingly employed to investigate both morphological and 
biochemical changes in different tissue types, for eventual application in the detection of tumors 
at an early stage.4-6 Fluorescence spectroscopy is well suited for the diagnosis of cancerous tissues 
because of its sensitivity to minute variations in the amount and the local environment of the native 
fluorophore present in the tissues.7-12 A number of fluorophores, ranging from structural proteins 
to various enzymes and coenzymes, some of which participate in the cellular oxidation-reduction 
processes, are present in the human tissue and can be excited by ultraviolet and visible light.7 The 
fluorophore, FAD (Flavin Adenine Dinucleotide), its derivatives and porphyrin are particularly useful 
as fluorescent markers, since they fluoresce in the higher wavelength visible region, when excited by 
lower wavelength visible light, thereby avoiding the potentially harmful ultraviolet radiation.
     The fluorescence emission can differ significantly in normal and cancerous tissues due to the 
differences in concentrations of absorbers13,14 and scatterers, as also the scatterer sizes.15 Some of 
the fluorophores like porphyrin give rise to weak fluorescence, since accumulation of porphyrin in 
tissue is a time consuming process. The absorption in the visible range occurs primarily due to the 
presence of blood, whose amounts vary in various tissue types.16 The presence of scatterers leads 
to randomization of light, thereby generating a depolarized component in the fluorescence spectra. 
Polarized fluorescence spectroscopy is useful in isolating the characteristic spectral features from the 
diffuse background. The parallel component of the fluorescence suffers fewer scattering events. In 
comparison, the intensity of the perpendicular component is not only affected more by scatterers, but 
is also quite sensitive to absorption, since the path traversed by the same in the tissue medium is more. 
Hence, the difference of parallel and perpendicular intensities, apart from being relatively free from 
the diffusive component,17,18 can be quite sensitive to microscopic biochemical changes including the 
effects of absorption in different tissue types.
     The analysis of spectral data involve both physical19-22 and statistical16,23 modeling of tissue 
types, as also statistical methods, e.g., principal component analysis16,24 for extracting distinguishing 
parameters for diagnostic purposes. The fact that biological tissues are complex systems, possessing 
substantial variations among individual patients, depending upon various factors such as age, progress 
of the disease, etc., makes modeling of the same rather difficult.25 In using statistical tools, difficulty 
often arises in relating the statistically significant quantities to physically transparent spectral variables.
     In recent times, wavelet transform has emerged as a powerful tool for the analysis of transient data 
and is particularly useful in disentangling characteristic variations at different scales.26 This linear 
transform isolates local features and leads to a convenient dimensional reduction of the data in the 
form of average coefficients, resembling the data itself. The wavelet coefficients, at various levels, 
encapsulate the variations at corresponding scales. Earlier studies, of the perpendicular component 
of the fluorescence spectra, by some of the present authors have indicated the usefulness of wavelet 
transform in identifying characteristic spectral features in the high frequency spectral fluctuations.27,28 
The statistical properties of these fluctuations showed differences between the tissue types.
     In this paper, we first present the results of a systematic analysis of both the average and high-pass 
coefficients of the wavelet transform, of the difference between parallel and perpendicular components 
of the fluorescence spectra, from normal and malignant human breast tissues. The average coefficients 
in the wavelet domain are less sensitive to experimental and statistical uncertainties. A number of 
parameters, capturing spectral features and subtle changes in the intensity profile of the diseased 
tissues, as compared to their normal counterparts, are identified in the wavelet domain. The physical 
origin of one of the distinguishing parameters may be ascribed to the changes in the concentration of 
porphyrin and the density of cellular organelles present in tumors.15,29 We then studied the behavior of 
the high pass coefficients and find distinguishing features between tissue types.
     Wavelet Transform: A brief overview
     Wavelet transform is known as a mathematical microscope, which isolates the variation 
and averages systematically at different scale due to its multi resolution ability, hence one can 
simultaneously have both time and frequency information, which is not possible through standard 
approaches like Fourier transform. The data under consideration is separated out into high frequency 
and low frequency components at multiple scales, known respectively as high pass and low pass 
coefficients. For example, high pass coefficients at level-1 represent variations at smallest scale and 
the subsequent higher level coefficients represent variations over bigger window sizes. The low pass 
coefficients at various levels represent average behavior of the data over corresponding window sizes. 
In discrete wavelet transform (DWT), the basis functions consist of father wavelet φ(x) and mother 
wavelet ψ(x) satisfying
                    ,           and                               (1)
φ and ψ are also square integrable:
                                                                                         (2)
        A completely orthonormal basis is constructed through translated and scaled versions of φ(x) and 
ψ(x). Explicitly, φ(x - k) ≡ φk (x) and ψ j,k ≡ 2 j/2 ψ (2j x - k), for -∞ ≤ k ≤ ∞ and     0 ≤ j ≤ ∞, provide a 
complete orthonormal basis through which any finite energy signal
)()( 2 RLtf ∈ 30 can be expanded as
 
        Here ck's are the low pass and  dj,k's are the high pass coefficients. For our analysis, we will make 
use of Haar wavelets, in which ck's can be interpreted as average of data points of appropriate size, 
around space location k, dj,k's are the high pass coefficients at level  j. These represent differences 
around location k, over a window size which depends on level j. Explicitly the wavelet coefficients are 
given by
 
 
                                                                  
 
For our application, we make use of the simplest Haar wavelet, since the interpretation of the wavelet 
coefficients is quite transparent here; it is also free from artifacts arising due to the finite size of the 
data. Haar basis is special, since it is symmetric and compactly supported. Below we explicate the 
procedure of extracting high-pass and low-pass coefficients for Haar wavelets, which makes their 
physical meaning clear. As mentioned before, discrete wavelet transform carries out a local weighted 
averaging and differentiation operation on a given, uniformly sampled data set. In case of Haar 
wavelets, this operation, modulo normalization, is precisely arithmetic averaging and differentiation. 
For illustration, let us consider a data set having four data points. At the lowest scale, i.e., level-1, the 
low pass (average) and high pass (wavelet) coefficients for the data set comprising of four data points 
a, b, c, d are respectively given by, 
 Because of Parseval's theorem, the energy/power i,e.,  is conserved:
 
This explains the origin of the normalizing factor  in front of the coefficient. The fact that, there are 
four data points, explains the presence of four independent coefficients, two low-pass and two high-
pass, from which, the data points can be reconstructed by the algebraic operations of addition and 
subtraction. One observes the absence of coefficients like   and  etc; the presence of which would have 
led to over counting. A straight-forward binning procedure with window size two would have yielded 
the low-pass coefficients.   
      At the second level, the window size is doubled, which leads to averaging and differentiation at a 
bigger scale involving four points, to produce the level -2, low-pass and high pass coefficients:
 
      In general, if the data length is , one can carry out an N-level decomposition. One notices that the 
window size is progressively increased in units of two. In the first level decomposition one obtains 
low-pass and high-pass coefficients, each of which are exactly half of the data size. In the next 
level, the level one low-pass coefficients are decomposed into level two low-pass coefficients and 
level two high-pass coefficients, each of size half that of the level one low-pass coefficients. This 
procedure is then carried on to the desired level of decomposition. This dyadic decomposition arises 
due to orthogonality and completeness of the Haar basis. Much like the orthogonal components of 
a vector along x, y and z directions, the obtained wavelet and low-pass coefficients are completely 
independent of each other. Instead of Haar, one can make use of wavelets like Daubechies basis, to 
isolate polynomial trends of the spectra from fluctuations. Lorentzian wavelets can be used to extract 
average Lorentzian line shapes from fluctuations, in spectral data analysis.
    The pictorial demonstration of discrete wavelet transform is presented in Fig.1 where N=0 
represents the original signal. It is worth mentioning that in case of Haar wavelet finding low pass 
coefficients at different levels amounts to binning of data in appropriate window sizes.
                         
             Fig.1. Pictorial demonstration of Discrete Wavelet Transform
     
     Experimental procedure
     The samples were excited by 488-nm wavelength plane polarized light from an Ar-ion laser 
(Spectra Physics 165, 5 W). The unpolarized and polarized fluorescence spectra were collected in 
right angle geometry using triplemate monochromator (SPEX-1877E and PMT, RCA C-31034). 
For polarized fluorescence, a depolarizer was used after the analyzer, in order to ensure that there 
was no preference of the selected directions of polarized fluorescence by the detection system. The 
components of fluorescence light that are parallel and perpendicular to the incident polarized light 
were measured in the 500- to 700-nm wavelength region. The tissue samples were kept in moist saline 
and frozen (at 40C) immediately after biopsy. After the biopsy, a part of the tissue sample was sent 
for histopathology and the other part was used for fluorescence measurements. The experiment was 
performed within a few hours of the surgery after thawing the sample.
     We have considered 192 intensity values, from 500nm to 691nm for analysis. The level-1 low 
pass coefficients are the averages of nearest neighbour data points; level-2 low pass coefficients 
represent averages of 4-data points etc. It is clear that, there are 96 level-1 coefficients, 48 level-2 
coefficients etc. For 192 data points, we can have a six level decomposition, with 3 sixth level low pass 
coefficients. It is observed that, progressive averaging of data in discrete wavelet transform reduces 
statistical and experimental uncertainties. The variations at lower level represent the high frequency 
components, corresponding to variations in smaller window sizes. As is characteristic of wavelet 
transform, it is seen that the normalized low pass coefficients resemble the data. While computing 
wavelet power one takes the sum of the square of wavelet coefficients at particular level e.g., low pass 
power at level-4 corresponds to sum of square of low pass coefficients of 4th level. For the purpose of 
normalization, we divide the power of a given level by the total power P: 
 
which is the sum of the squares of all the data points. Similarly one can compute the normalized high 
pass power. 
     In our earlier studies,27,28 we have investigated the statistical properties of the lower level high 
pass coefficients and have observed significant differences between cancer and normal tissues. In 
the present paper, the structure of the low pass coefficients and low pass power of six levels will be 
investigated, as also statistical behavior of the low level high pass coefficients.
      Results and Discussion
     In total, 28 breast cancer tissue samples were studied, out of these, 23 samples came with their 
normal counterparts. The tissue samples were excited by 488 nm wavelength polarized light and 
the parallel and perpendicularly polarized fluorescence light were measured from 500 to 700 nm. 
Differences of parallel and perpendicular components of fluorescence intensity (I║ - I┴) versus 
wavelength profiles for all the tissue samples were analyzed by Haar wavelets,30 for which purpose we 
have considered the first 192 intensity values. Typical samples of the spectra are seen in Fig. 2 and 3.
 
      
Fig.2. Typical plots of (a) parallel and perpendicular components (b) difference of the  
          parallel and perpendicular components of intensities of fluorescence spectra of
          normal tissue.
 
     
Fig.3. Typical plots of (a) parallel and perpendicular components (b) difference of the 
          parallel and perpendicular components of intensities of fluorescence spectra of
          cancer tissue.
 
Fig.4. Plots of low pass coefficients of cancer and normal tissues for (a) level-3 (b)    
          level-4 and (c) level-5 average coefficients. The fourth-level coefficients    
          highlight the 630nm weak emission peak in cancerous tissue. 4(d) shows a    
          typical low pass power plot of the difference of parallel and perpendicular    
          components of the fluorescence spectra of cancer and normal tissues. The rate of  
          decrease of low pass power, as a function of levels, is slower in cancer tissues.
 
     It is found that a clear difference between cancer and normal tissues emerge at fourth level. In 
particular, relatively higher value for a normalized low pass coefficient at the third quarter of the 4th 
level decomposition is seen in cancer tissues as shown in Fig. 4(b). It should be noted that at the 4th 
level, each coefficient corresponds to average of 16 original intensity values. This structure is absent 
at the fifth level, as seen in Fig. 4(c), because of averaging over a bigger window size and is not 
transparent at the third level as is clear from Fig. 4(a). So a suitable block averaging highlights the 
presence of a weak fluorophore (porphyrin) in cancerous spectra which is not present in the normal 
case. The 5th level normalized low pass coefficients do not show significant variation between cancer 
and normal tissues, except at the tail end, where the cancer values fall off slowly as compared to their 
normal counter parts. For the purpose of comparison between normal and cancer tissue fluorescence 
the normalized low pass coefficients at 3rd, 4th and 5th levels are shown in Fig. 4. As pointed out earlier, 
at the 4th level the normalized low pass coefficients of the cancer tissue fluorescence show a minor 
peak at the 3rd quadrant. The same is averaged out at the 5th level. At 3rd level, one sees many minor 
peaks apart from one at the 3rd quadrant. Significantly the normalized wavelet powers representing 
the strength of the variation at different levels also differ between normal and cancer tissues at the 
same level. A typical plot revealing this aspect is given in Fig. 4(d). It may be noted from equation(5) 
that the low pass power is the sum of square of low pass coefficients at that level and hence would 
highlight the differences in normalized low pass coefficients between normal and cancerous tissues. 
The behavior of the normalized low pass powers at different levels also reveal substantial differences 
between tissue types, as is clearly indicated in Table-1.
     In case of Haar wavelet fourth level corresponds to averaging of 16 intensity values of original data 
set. In third level it corresponds to averaging 8 points whereas in fifth level it corresponds to averaging 
of 32 points. The fact that porphyrin peak manifests at the fourth level, indicates that the spectral width 
of this fluorophores is of the order of the above window size. The absence of this fluorophore in case 
of normal samples makes the intensities fall faster in 620-670nm regime. We would like to add that 
we have done a block averaging with window size ranging from 10, 12, 14, 16 and 18 nm. It is found 
that the peak at the third quadrant begins to manifest from the window size 14 nm and starts decreasing 
around 18 nm.
                               
 Fig.5. Local maxima at third quarter of fourth level low-pass coefficients of cancer and  
           normal breast tissues.
 
     The normalized low-pass coefficients in the third quarter of the 4th level have been considered 
for illustrating the minor peak. The local maxima at third quarter of fourth level normalized low-
pass coefficients of cancer samples are more than 0.1 while those of normal tissues are less than 0.1, 
with a sensitivity of 100 % and specificity of 83 %. The scatter plot is shown in Fig.5. It should be 
noted here that the values for normal tissues which are more than 0.1 still show lower values than the 
corresponding tumors, consistent with all the other samples. Thus intra-patient diagnosis gives a clear 
distinction between cancer and normal tissues. Variations in inter-patient diagnosis may be due to 
the fact that, the growth of tumor depends on genetic (major genes, modifier genes) and non-genetic 
factors (birth, age, weight/diet, exercise, environmental exposures, etc).3 The above fourth level 
normalized low-pass coefficient, originate from the fluorescence signals around 630nm of the original 
data, corresponding to the porphyrin emission peak.
     FAD and porphyrin are the major fluorophores that fluoresce in the visible wavelength regime, with 
peak intensities at 530 and 630 nm respectively. These fluorophores are considered as contrast agents 
for cancer detection.7,11 It has been suggested that deficiency of ferrochelatase, the enzyme required 
for conversion of protoporphyrin IX (PpIX) to heme, in tumors results in accumulation of PpIX in 
these tissues relative to the normal ones.11 Such accumulation changes the relative concentration 
of these fluorophores thus altering the fluorescence spectra significantly, which in turn changes the 
peak heights of the emission bands of the two fluorophores. The scattering centers are known to 
enhance the fluorescence intensity.31 Thus the large size of cell suspensions, higher density of cells 
and accumulation of more porphyrin in tumors may possibly contribute to the small peak at 630 nm 
wavelength region. Since all tissues studied in this work were non-necrotic and non-fungating, as 
corroborated histopathologically, protoporphyrin emission may not be due to bacterial action.32
     A systematic analysis yields that, the normalized low pass powers at 4th level consistently differ 
between tissue types. Table-1 depicts normalized low pass powers of cancerous and corresponding 
normal tissues at the fourth level. The third column shows the values of fourth level normalized 
low pass powers and the second indicates the tissue type. It is observed from the table-1 that, the 
normalized low pass powers is more in cancerous tissues than its normal counterpart in ductal 
carcinoma (grade I, II, III), with a sensitivity of 80%. Interestingly, it is also found that, this value is 
less in tissues showing metastasis or with fatty tissues attached. These points need to be checked in a 
larger data base. 
     It is further observed that, normalized low pass powers of cancerous tissues decrease more slowly 
as a function of levels, as compared to their normal counter parts. Table-1 also gives the corresponding 
slope values, capturing these differences in the rate of fall; the 
Table-I: 4th level low pass powers of cancer and normal fluorescence spectra and slope     
              values of the normalized six levels low pass power plots
 
Sr. 
No.
Description of tissue
type
4th level low pass 
power of
Slope values of the normalized
six level low pass power
  Cancer Normal Cancer Normal Difference
1. Ductal carcinoma grade-III 0.907643 0.740373 -0.011474 -.037925 -0.0265
2. Cystosarcoma 0.241762 0.161403 -0.102240 -0.108020 -0.0058
3. Ductal carcinoma grade-III  0.581773 0.986615 -0.012917 -0.012797 0.0001
4. Intraductal carcinoma   
(poorly defined)
0.940750 0.881308 -0.011890 -0.016320 -0.0044
5. Ductal carcinoma grade-III 0.934995 0.822425 -0.102240 -0.108020 -0.0058
6. Ductal carcinoma   0.975588 0.953657 -0.008624 -0.016169 -0.0075
7. Cystosarcoma   0.739220 0.884085 -0.037675 -0.020604 0.0171
8. Ductal carcinoma grade-II 
positive for metastasis
0.818529 0.903577 -0.023613 -0.015374 0.0082
9.  0.899315 0.887338 -0.015041 -0.017573 -0.0025
10. Ductal carcinoma grade-III 
positive for metastasis
0.946701 0.922604 -0.010214 -0.011873 -0.0017
11. Ductal carcinoma grade-II 0.717098 0.690419 -0.031467 -0.026810 0.0047
12. Ductal carcinoma   0.346617 0.672974 -0.015834 -0.025814 -0.0100
13. Ductal carcinoma   0.995145 0.993628 -0.005429 -0.006476 -0.0010
14. Ductal carcinoma grade-II 0.985754 0.967677 -0.006719 -0.015287 -0.0086
15. Ductal carcinoma grade-II 0.988722 0.236050 -0.005074 -0.059195 -0.0541
16. Ductal carcinoma grade-III 0.980755 0.961066 -0.009140 -0.019149 -0.0100
17. Ductal carcinoma grade-II 0.994246 0.901727 -0.007558 -0.021904 -0.0143
18. Ductal carcinoma grade-III 0.993581 0.985420 -0.006816 -0.092203 -0.0854
19. Ductal carcinoma grade-III 
positive for metastasis
0.952731 0.956181 -0.012288 -0.011054 0.0012
20. Ductal carcinoma grade-I 0.988466 0.963549 -0.006358 -0.014993 -0.0086
21. Ductal carcinoma grade-II 0.990160 0.915598 -0.005952 -0.024105 -0.0182
22. Cystosarcoma   0.994139 0.918831 -0.007244 -0.016744 -0.0072
23. Lobular carcinoma   0.305293 0.218660 -0.064706 -0.076012 -0.0113
 
fourth column shows the differences between the slope values. The slopes have been calculated by 
the linear fit of low pass power profile. It is observed that, fluctuations contribute significantly more 
to the total power in normal tissue fluorescence than their tumor counterparts. As Fig. 4(d) indicates, 
fluctuations contribute significantly to normal spectra and the average power measured through 
normalized low-pass coefficients decreases rapidly as a function of level for normal tissues. However 
for the cancerous cases, the average power remains quite high up to 6th level. It is worth reminding 
that due to Parseval's theorem, the total power is conserved in the orthogonal Haar basis. Therefore, if 
the fluctuations are high at certain level, the normalized low-pass power is small at the corresponding 
level.   
       The fact that we have dealt with normalized energies, makes this comparison meaningful. 
Similarly the slope, in the normalized low-pass coefficients (which are similar to the data itself since 
they represent averaged data points) indicates a sudden variation of the spectral profile in normal tissue 
fluorescence which is not present in cancerous cases.
           Very interestingly, like the normalized low pass power, the cancerous samples with attached 
fatty tissues and the tissue types which are positive for metastasis show a higher steepness than the 
corresponding normal ones.
     It may be noted that the above-mentioned three parameters also distinguish tumors of different 
grades. It is found that for grades I and II cancerous tissues, the values of the local low-pass maxima 
at the third quadrant are less than 0.2, but more than 0.2 in the grade III cancers, with a sensitivity of 
75 %.
     It is worth emphasizing that in the discrete wavelet transform, the average normalized low pass 
coefficients capture the broad band features in the spectra at a suitable scale and the normalized 
high pass coefficients extract the high frequency behavior. The orthogonal property ensures that the 
extracted features at different scales are independent of each other. It is clear that the normalized high 
pass coefficients can capture characteristic spectral variations, as also spectral fluctuations at different 
scales, whose property can be studied for tissue discrimination.
     For Haar wavelets, the low pass coefficients represent average values of the data at different 
scales, whereas the high pass coefficients are the corresponding differences. At level-1 the wavelet 
coefficients therefore represents nearest neighbor differences which capture sudden changes in 
spectral intensities. Some of these variations can be ascribed to random fluctuations, arising from the 
randomization process in tissue light scattering and others to sharp changes in the spectral profile. 
The progressive averaging removes sharp variations, as also the random fluctuations. Hence, at higher 
levels the high pass coefficients capture the broader spectral variations and the low pass coefficients, 
the block averaged spectral intensity. The slopes of normalized low pass power shows sudden changes 
in spectral variations between 3rd and 4th levels. This discriminates the normal and diseased tissues 
well. It arises from the characteristic spectral variations present in the 3rd and 4th level, related to 
porphyrin emission.
     In order to show the advantage of wavelet transform over the straightforward binning procedure 
(low pass), the high- pass features (since the normalized high pass coefficients are differences of 
intensities) have been carefully analyzed. The fact that, the normalized wavelet coefficients represent 
high-frequency variations makes them ideal to isolate characteristic spectral variations, from random 
ones. It is seen that high level normalized high pass coefficients do not give significant discrimination 
between tissue types (Table-2). However, the normalized spectral fluctuations, the normalized high-
pass coefficients divided by their corresponding normalized low-pass coefficients, which are much 
more reliable for a statistical analysis at level-1 show clear distinction between diseased and normal 
tissues. 
       It is found that there is significant randomization of fluctuations27 in case of cancerous tissue 
spectra, as compared to their normal counterparts. The fact that, cancerous tissues have nuclei of 
irregular shapes, which are much more tightly packed as compared to the normal tissues, may explain 
this observed feature. Hence in the difference of parallel and perpendicular spectra, which is free of the 
diffusive component, the spectral fluctuations in 
 
            Table- II: Result of the analysis of the high-power coefficients showing
                             differences in grades of cancer and normal
 
 
 
 
 
Sr. No. Description of tissue
type
Values of high pass power of third 
level
  Cancer Normal Difference
1. Ductal carcinoma grade-III 2.18E-02 3.08E-02 -8.99E-03
2. Cystosarcoma 2.53E-02 3.85E-02 -1.32E-02
3. Ductal carcinoma grade-III  3.10E-02 4.71E-03 2.63E-02
4. Intraductal carcinoma   
(poorly defined)
1.14E-02 3.12E-02 -1.98E-02
5. Ductal carcinoma grade-III 1.41E-02 2.27E-02 -8.56E-03
6. Ductal carcinoma   7.67E-03 1.70E-02 -9.35E-03
7. Cystosarcoma   6.37E-02 2.26E-02 4.11E-02
8. Ductal carcinoma grade-II 
positive for metastasis
1.76E-02 2.63E-02 -8.71E-03
9.  1.14E-02 1.91E-02 -7.68E-03
10. Ductal carcinoma grade-III 
positive for metastasis
1.69E-02 1.74E-02 -5.66E-04
11. Ductal carcinoma grade-II 4.73E-02 3.27E-02 1.46E-02
12. Ductal carcinoma   1.95E-02 1.76E-02 1.97E-03
13. Ductal carcinoma   7.77E-03 1.04E-02 -2.60E-03
14. Ductal carcinoma grade-II 1.05E-02 1.52E-02 -4.69E-03
15. Ductal carcinoma grade-II 4.95E-03 5.35E-02 -4.85E-02
16. Ductal carcinoma grade-III 5.23E-03 1.80E-02 -1.27E-02
17. Ductal carcinoma grade-II 1.05E-02 2.07E-02 -1.01E-02
18. Ductal carcinoma grade-III 8.42E-03 1.59E-02 -7.52E-03
19. Ductal carcinoma grade-III 
positive for metastasis
9.46E-03 1.26E-02 -3.15E-03
20. Ductal carcinoma grade-I 8.49E-03 1.77E-02 -9.17E-03
21. Ductal carcinoma grade-II 5.44E-03 3.36E-02 -2.82E-02
22. Cystosarcoma   1.08E-02 1.88E-02 -8.01E-03
23. Lobular carcinoma   1.73E-02 2.20E-02 -4.72E-03
  
 
 
 
 
 
 
 
 
 
 
 
cancer are devoid of characteristic fluctuations and show Gaussian random behavior28. The normal 
tissue's fluorescence spectra, on the other hand, retain their characteristic spectral variations, thereby 
showing a bigger spread in their wavelet coefficients and hence a larger standard deviation, as seen in 
Fig.6. A characteristic plot of the normalized high-pass power calculated for every scale is shown in 
Fig.7. For all scales, malignant tissues show 
        
      Fig.6. Standard deviations of the spectral fluctuations of the cancer and normal 
                 tissues, captured through the high pass coefficients at level-1.
 
                       
Fig.7. Normalized high pass power as a function of level, clearly low for cancer 
          for all levels and showing considerable difference at 3rd level.
 
weaker power compared to their normal counter-parts, the difference becomes considerably higher at 
3rd level. Table-2 depicts the results of the analysis of the high-pass coefficients for all samples.
     In conclusion, the systematic separation of variations at different wavelength scales from the broad 
spectral features pinpoints several quantifiable parameters to distinguish cancer and normal tissues. 
These distinguishable features are related with the biochemical and morphological changes. The 
spectral profile of diseased and the non-diseased tissues behave very differently, which manifest in 
the difference of the low pass power profiles. The fact that these characteristic signatures are based 
on higher level average coefficients makes them robust and less susceptible to experimental and 
statistical uncertainties. It is found that low level normalized high pass coefficients differ significantly 
between cancer and normal tissues. It is worth emphasizing that a straightforward averaging with 
arbitrary window sizes would not respect the orthogonality property, and hence would not allow an 
independent separation of fluctuations and average behavior at multiple scales. We observe that, 
scaling and translation are the key operations, which enable one to carry out a local analysis at desired 
scale and leads to independent wavelet coefficients, devoid of redundancy. This procedure is common 
to all discrete wavelets, where suitable form of weighted averaging and differentiation involving more 
than two points are carried out. The need for the early identification and constant monitoring of breast 
cancer for a large population makes this method eminently suitable since the same can be automated. 
We intend to analyze more samples and different type of cancers through both continuous and discrete 
wavelets to look for subtle spectral variations.
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